AI Model Chai-2 Revolutionizes Antibody Design, Cuts Drug Development Time
Chai Discovery's AI model, Chai-2, introduces zero-shot antibody design with a 16%-20% success rate, accelerating drug development from months to weeks. Its multimodal capabilities extend to mini-proteins, promising breakthroughs in treating complex diseases.
